RSMDF — RESMED INC
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 943819 ·
Last close
$16.99
Market Cap
$24.65B
52W High
$25.54
52W Low
$11.85
ADV30
85
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,431,406,000 | 890,979,000 | 499,810,000 | 398,732,000 | 8,784,285,000 | 1,660,513,000 | 2,292,374,000 |
| Dec 2025 | 1,422,808,000 | 878,724,000 | 497,595,000 | 392,593,000 | 8,503,370,000 | 1,417,069,000 | 2,182,491,000 |
| Sep 2025 | 1,335,582,000 | 820,820,000 | 462,347,000 | 348,536,000 | 8,308,352,000 | 1,383,848,000 | 2,187,088,000 |
| Jun 2025 | 1,347,993,000 | 820,068,000 | 456,571,000 | 379,705,000 | 8,174,391,000 | 1,209,450,000 | 2,206,532,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,889,964,000
Investing CF
$-295,261,000
Financing CF
$-907,752,000
CapEx
$-153,701,000
Dividends Paid
$-340,162,000
Buybacks
$-600,045,000
EPS Diluted TTM
$1.05
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$6,958,779,000
Inventory
$911,876,000
Receivables
$1,045,943,000
ST Investments
—
EBIT TTM
$1,916,323,000
Pretax Income TTM
$1,903,306,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,537,788,928
EBITDA
$2,119,501,056
Free Cash Flow
$1,446,655,104
Enterprise Value
$9,040,688,128
Total Cash
$1,660,513,024
Total Debt
$843,169,024
Shares Out
1,450,563,840
Trailing EPS
$1.04
Book Value
$11.19
ROE
25.2%
ROA
14.7%
Div Yield
1.41%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 5,146,327,000 | 1,687,394,000 | 1,400,723,000 | 8,174,391,000 | 2,206,532,000 | — | 1,751,588,000 |
| Jun 2024 | 4,685,297,000 | 1,384,121,000 | 1,020,951,000 | 6,872,394,000 | 2,008,351,000 | — | 1,401,260,000 |
| Jun 2023 | 4,222,993,000 | 1,151,997,000 | 897,556,000 | 6,751,708,000 | 2,621,805,000 | — | 693,299,000 |
| Jun 2022 | 3,578,127,000 | 1,002,150,000 | 779,437,000 | 5,095,853,000 | 1,735,102,000 | — | 351,147,000 |
TTM Snapshot
Revenues TTM
$4,958,138,000
NetIncome TTM
$1,290,228,000
OpCashFlow TTM
$0
Assets (Latest)
$8,174,391,000
Forward EPS
$0.41
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FSNUY | Fresenius SE & Co. KGaA | $24.38B | $10.82 | — |
| RYLPF | KONINKLIJKE PHILIPS NV | $25.33B | $26.06 | — |
| WST | WEST PHARMACEUTICAL SERVICES INC | $23.64B | $334.66 | — |
| PHG | KONINKLIJKE PHILIPS NV | $25.76B | $26.50 | — |
| RMD | RESMED INC | $28.57B | $196.94 | — |
News headlines (Yahoo Finance, 1h cache)
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
2026-06-09 12:55 · Yahoo
ResMed (RMD) Acquires Noctrix Health to Expand Sleep Disorder Portfolio
2026-06-05 21:24 · Yahoo
ResMed completes $340m Noctrix Health acquisition
2026-06-04 11:17 · Yahoo
3 Big Reasons RMD Should Be On Your Watchlist
2026-06-03 17:43 · Yahoo
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide?
2026-06-03 12:14 · Yahoo
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
2026-06-03 11:40 · Yahoo
Resmed completes $340M Noctrix takeover
2026-06-02 06:30 · Yahoo
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
2026-06-01 20:05 · Yahoo
Do Wall Street Analysts Like ResMed Stock?
2026-05-25 10:35 · Yahoo
2 Healthcare Stocks to Research Further and 1 We Find Risky
2026-05-23 11:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.